MRNA Moderna Inc
Company Analysis
Latest News
🔴 Moderna is trading 4.2% down with no verified company-specific catalyst
Moderna is trading 4.2% lower at $194.67, with no verified company-specific announcement identified to explain the October 6 decline. - The October 5 gain...
🟢 Moderna is trading 4.5% up today with no verified catalyst reported
Moderna is trading at $198.57, up 4.51%, with no clearly verified Moderna-specific announcement explaining the October 5 move. - Nasdaq-100 inclusion,...
Moderna Joins Nasdaq-100, Prompting Index Funds to Buy Shares
Nasdaq said Moderna (MRNA) will join the Nasdaq-100 Index before the market opens on October 9, 2026. Moderna will replace Warner Bros. Discovery (WBD) in the...
Moderna Loses Government-License Defense in Northwestern Patent Case
A federal judge in Delaware rejected Moderna’s argument that a U.S. government license stemming from federally funded research shielded the company from patent...
🟢 Moderna is trading 4.02% up with no clear catalyst identified
Moderna is trading at $200.31, up 4.02% on October 1, 2026; no clear company-specific announcement explaining the gain appeared in available search results. -...
Moderna Appoints Former Executive Juan Andres to New Chief Operating Officer Role
Moderna announced it has created a new Chief Operating Officer (COO) role and appointed former executive Juan Andres to the position, effective October 5,...
🔴 Moderna is trading 4.03% down in pre-market with no confirmed catalyst
Moderna is trading 4.03% down at $195.26 in pre-market on September 30; no reliable report directly ties the move to a new announcement. - A Delaware judge...
🟢 Moderna is trading 5% up; no clear catalyst identified
Moderna is trading 5.35% higher at $207.84 on September 29, 2026, with no reliable report identifying a specific catalyst. - Major indices are nearly flat,...
🔴 Moderna is trading 4.52% down today amid oil-driven inflation concerns
Moderna is trading 4.52% lower at $189.90 amid broader risk-off sentiment linked to higher oil and renewed inflation concerns. - President Trump’s rejection of...
🔴 Moderna is trading 4.23% down in pre-market amid weaker global risk sentiment
Moderna is trading 4.23% down at $190.47 in pre-market on September 28; weaker global risk sentiment may be contributing, but no clear new company-specific...
🟢 Moderna is trading 4.72% up today after Phase 3 trial met recurrence-free-survival endpoint
Moderna is trading 4.72% up at $190.70 after positive Phase 3 INTerpath-001 results for intismeran autogene with Merck’s Keytruda. - The trial met its...
🟢 Moderna is trading 4.48% up today after Phase 3 trial met survival endpoints
Moderna is trading 4.48% up now at $190.74 as investors respond to positive Phase 3 melanoma results for intismeran autogene with Merck’s Keytruda. -...
🟢 Moderna is trading 5% up today after positive Phase 3 melanoma results
Moderna is trading 5% up at $181.61 after Moderna and Merck announced positive Phase 3 melanoma results. - The rally extends Moderna’s 12.27% gain on...
Moderna Lands the Biggest Stage in Cancer Medicine — But Can a Conference Slot Justify a $7 Billion Single-Day Gain?
Shares of Moderna surged 10.8% to $170.63 Monday after the company announced its personalized mRNA melanoma vaccine data secured a coveted Presidential...
🟢 Moderna is trading 10.77% up today after melanoma-vaccine data secured Presidential Symposium placement
Moderna is trading $170.63 (+10.77%) after announcing on September 21, 2026, that Phase 3 melanoma-vaccine data for intismeran autogene will receive a...
🟢 Moderna is trading 5% up today as U.S. equities open higher
Moderna is trading 5% up now at $161.72, as U.S. equities open higher. - The S&P 500 is up 0.65%, while the Nasdaq Composite is up 0.90%. - The move appears...
Moderna loses key mRNA patent, reversing European legal victories
The European Patent Office (EPO) Boards of Appeal revoked Moderna’s patent EP 3 590 949. This patent is central to Moderna's ongoing legal disputes with Pfizer...
🟢 Moderna is trading 10% up today as markets recover after September 16 rate hike
Moderna is trading at $160.30, up +10.08%, as U.S. markets recover after the Federal Reserve’s September 16 rate hike, which removed immediate policy...
🟢 Moderna is trading 6.74% up today as markets recover after September 16 Fed decision
Moderna is trading at $158.65, with a +6.74% gain during the September 17, 2026 session as broader U.S. markets recover after the Federal Reserve’s September...
🟢 Moderna is trading 4.3% up in pre-market after Fed’s September 16 rate decision
Moderna is trading 4.32% up at $151.91 after a firm broader-market recovery following the Federal Reserve’s September 16 rate decision. - Major U.S. indices...